Literature DB >> 21897139

Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.

Peter Veldman1, Kathryn Colby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897139     DOI: 10.1097/IIO.0b013e31822d6af1

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  5 in total

1.  Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.

Authors:  Lili Zhang; Zhitao Su; Zongduan Zhang; Jing Lin; De-Quan Li; Stephen C Pflugfelder
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

Review 2.  New agents for treating dry eye syndrome.

Authors:  Simon E Skalicky; Con Petsoglou; Avinash Gurbaxani; Clare L Fraser; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

3.  Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin.

Authors:  David W Stroman; Keri Mintun; Arthur B Epstein; Crystal M Brimer; Chirag R Patel; James D Branch; Kathryn Najafi-Tagol
Journal:  Clin Ophthalmol       Date:  2017-04-13

4.  Short-term azithromycin treatment promotes cornea allograft survival in the rat.

Authors:  Katrin Wacker; Sophy Denker; Antonia Hildebrand; Philipp Eberwein; Thomas Reinhard; Johannes Schwartzkopff
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

5.  Composition and Diversity of the Ocular Surface Microbiota in Patients With Blepharitis in Northwestern China.

Authors:  Changhao Wang; Xiuhong Dou; Jian Li; Jie Wu; Yan Cheng; Na An
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.